BMO Capital lifts DuPont stock price target to $116 from $112

Published 11/03/2025, 03:32 am
BMO Capital lifts DuPont stock price target to $116 from $112

On Monday, BMO Capital Markets sustained their positive outlook on DuPont shares (NYSE:DD), raising the price target from $112.00 to $116.00, while maintaining an Outperform rating. With a market capitalization of $32.71 billion and revenue of $12.39 billion, the firm’s analysts believe DuPont presents one of the more compelling investment opportunities within the chemical industry, with potential for significant value realization in the foreseeable future. According to InvestingPro data, six analysts have recently revised their earnings estimates upward for the upcoming period.

The optimism from BMO Capital is driven by DuPont’s exposure to stable and improving end markets, along with the anticipated division of the company into two separate entities: ElectronicsCo and New DuPont. The split, expected to occur within the next 6-12 months, is seen as a key event that could unlock value for shareholders. The strong analyst consensus, currently at 1.8 (Buy), supports this positive outlook.

BMO Capital’s analysis delves into the prospects of both emerging companies, concluding that a $116 target price is justified. With DuPont’s shares currently trading below $79 and at approximately 11.5 times earnings, BMO Capital views the stock as substantially undervalued. They anticipate that the perceived undervaluation will be corrected as the company nears its split and subsequently when the new stocks are assigned their long-term Global Industry Classification Standard (GIC) codes and become part of investor benchmarks.

The firm’s analysts have identified DuPont as a Top Pick, indicating strong confidence in the stock’s performance potential. The upcoming corporate split is seen as a transformative event that could catalyze the stock’s revaluation in the market.

In other recent news, DuPont has introduced WAVE PRO, a new online modeling tool aimed at optimizing ultrafiltration water treatment processes. This tool is part of DuPont’s ongoing efforts to advance water treatment technologies and is available at no cost through their WaterApp platform. In analyst updates, UBS has raised its price target for DuPont to $103 while maintaining a Buy rating, highlighting the company’s strong performance in the electronics sector and organic growth projections for 2025. Similarly, BMO Capital Markets increased its price target to $112, maintaining an Outperform rating, and noted DuPont’s robust fourth-quarter performance in key segments such as Electronics, Water, and Healthcare. Barclays (LON:BARC) also upgraded DuPont’s stock from Underweight to Equalweight, raising the price target to $89, citing strong growth in the electronics segment driven by AI technology applications and semiconductor advancements. Additionally, DuPont announced the appointment of Kurt McMaken to its Board of Directors, bringing his extensive financial and strategic planning expertise to the company. These developments reflect a positive outlook for DuPont, with analysts expressing confidence in its future growth and performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.